权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

CRU - Clinical Research Unit Shared Resource

CRU - 临床研究单位共享资源

基本信息

批准号：
7944617
负责人：
DENNIS J SLAMON
金额：
$ 76.79万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-04-02 至 2013-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7944617
关键词：
Basic Science Budgets Cancer Center Support Grant Categories Clinic Clinical Clinical Research Clinical Trials Communities Community Clinical Oncology Program Complex Comprehensive Cancer Center Continuing Education Cost Analysis Data Development Employee Enrollment Eponyms Faculty Floor Funding Future Growth Guidelines House Staffs Housing International Literature Malignant Neoplasms Monitor Network-based Nursing Research Oncologist Patients Phase Philanthropic Fund Play Positioning Attribute Practical trial Principal Investigator Protocols documentation Public Domains Reagent Reporting Research Research Personnel Resource Sharing Resources Role Running Safety Series Services Site Structure Therapeutic Time Training Translational Research Update Wages Work anticancer research authority base community setting design falls follow-up innovation interest investigator-initiated translational research member oncology organizational structure programs protocol development research study square foot

项目摘要

Clinical Research Unit The Clinical Research Unit (CRU) of the Jonsson Comprehensive Cancer Center (JCCC) was established in 1993 as the first major facility for support of clinical cancer research at UCLA. The establishment of this unit was critical to move the Division of Clinical/Transitional Research of the JCCC and its investigators into a position from which it could play a significant role in investigator-initiated, cooperative group and industrysponsored clinical research in cancer. Since the 2002 renewal, the JCCC has formed a separate 501 (c)(3) that allows us to partner with community oncologists in the accrual of subjects to high-priority studies. Translational Oncology Research International (TORI) has a formal Memorandum of Understanding that defines its relationship to the JCCC. Partial funding (20% of the full operating budget)is requested to support the CRU. The remainder of the funds come from various institutional resources.

临床研究单位琼森综合癌症中心（JCCC）的临床研究单位（CRU）成立于年。 1993年，作为加州大学洛杉矶分校支持临床癌症研究的第一个主要设施。该股的设立将JCCC的临床/过渡研究部门及其研究人员转移到一个它可以在发起者发起的合作团体和工业赞助的活动中发挥重要作用癌症的临床研究自2002年更新以来，JCCC已经形成了单独的501（c）（3），使我们能够与社区合作肿瘤学家参与高优先级研究的受试者招募。国际转化肿瘤学研究组织（TORI）有一个正式的谅解备忘录，确定了它与JCCC的关系。需要部分资金（全部业务预算的20%）来支持CRU。其余资金来自不同的机构资源。